Ipomoea species, glorious but dangerous plants: A case-series.

Autor: Huleux L; Pharmacology Department, Addictovigilance Center, French addictovigilance network (FAN), Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Inserm, CHU of Lille, University of Lille, 59000 Lille, France., Lefebvre E; Service de pharmacologie clinique - centre d'évaluation et d'information sur la pharmacodépendance-addictovigilance, CHU de Nantes, Nantes université, 44000 Nantes, France., Azzouz R; Centre antipoison, pôle de l'urgence, CHU de Lille, 59000 Lille, France., Charuel L; Centre d'évaluation et d'information sur la pharmacodépendance-addictovigilance de Paris, centre antipoison de Paris, 75000 Paris, France., Caous AS; Pharmacology Department, Addictovigilance Center, French addictovigilance network (FAN), Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Inserm, CHU of Lille, University of Lille, 59000 Lille, France., Deheul S; Pharmacology Department, Addictovigilance Center, French addictovigilance network (FAN), Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Inserm, CHU of Lille, University of Lille, 59000 Lille, France., Victorri-Vigneau C; Service de pharmacologie clinique - centre d'évaluation et d'information sur la pharmacodépendance-addictovigilance, CHU de Nantes, Nantes université, 44000 Nantes, France., Le Boisselier R; Pharmacology Department, Addictovigilance Center of Britany and Normandy areas, 14033 Caen, France., Bordet R; Pharmacology Department, Addictovigilance Center, French addictovigilance network (FAN), Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Inserm, CHU of Lille, University of Lille, 59000 Lille, France., Thorigné S; Pharmacology Department, Addictovigilance Center of Britany and Normandy areas, 14033 Caen, France., Carton L; Pharmacology Department, Addictovigilance Center, French addictovigilance network (FAN), Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Inserm, CHU of Lille, University of Lille, 59000 Lille, France. Electronic address: louise.carton@univ-lille.fr.

Publikováno v: Therapie [Therapie] 2024 Sep-Oct; Vol. 79 (5), pp. 606-609. Date of Electronic Publication: 2024 Feb 02.

Comparison of biomarker for diagnosis of nitrous oxide abuse: challenge of cobalamin metabolic parameters, a retrospective study.

Autor: Grzych G; CHU de Lille, Service Hormonologie Métabolisme Nutrition Oncologie, 59000, Lille, France. guillaume.grzych@chu-lille.fr.; CHU de Lille - Centre de Biologie Pathologie Génétique - Service Hormonologie Métabolisme Nutrition Oncologie, 1 boulevard du professeur Jules Leclercq, 59000, Lille, France. guillaume.grzych@chu-lille.fr., Deheul S; CHU de Lille, Centre d'Addictovigilance des Hauts-de-France, Centre Anti-Poison, Service de Pharmacologie, 59000, Lille, France., Gernez E; CHU de Lille, Service Hormonologie Métabolisme Nutrition Oncologie, 59000, Lille, France., Davion JB; CHU de Lille, Clinique de Neurologie, 59000, Lille, France., Dobbelaere D; Medical Reference Center for Inherited Metabolic Diseases, Jeanne de Flandre University Hospital and RADEME Research Team for Rare Metabolic and Developmental Diseases, EA 7364 CHU Lille, 59000, Lille, France., Carton L; CHU de Lille, Centre d'Addictovigilance des Hauts-de-France, Centre Anti-Poison, Service de Pharmacologie, 59000, Lille, France.; CHU de Lille, Service d'Addictologie, 59000, Lille, France., Kim I; CHU de Lille, Service Hormonologie Métabolisme Nutrition Oncologie, 59000, Lille, France., Guichard JC; Unité Sanitaire en Milieu Pénitentiaire USMP, 59000, Lille, France., Girot M; CHU Lille, Service des Urgences adultes, F-59000, Lille, France., Humbert L; CHU de Lille, Service d'Endocrinologie, Diabétologie et Maladies métaboliques, 59000, Lille, France., Bennis A; CH de Roubaix, Service de Neurologie, 59100, Roubaix, France., Joncquel M; CHU de Lille, Service Hormonologie Métabolisme Nutrition Oncologie, 59000, Lille, France., Chieux V; CH Saint Philibert, Laboratoire des hôpitaux du GHICL, 59160, Lomme, France., Joly A; Agence Régionale de Santé Hauts de France, Amiens, France., Nasserdine P; CHU de Lille, Service d'Explorations Fonctionnelles Cardiovasculaires, 59000, Lille, France., Trillot N; CHU de Lille, Institut Hématologie Transfusion, 59000, Lille, France., Douillard C; Medical Reference Center for Inherited Metabolic Diseases, Jeanne de Flandre University Hospital and RADEME Research Team for Rare Metabolic and Developmental Diseases, EA 7364 CHU Lille, 59000, Lille, France.; CHU de Lille, Service d'Endocrinologie, Diabétologie et Maladies métaboliques, 59000, Lille, France., Pigny P; CHU de Lille, Service Hormonologie Métabolisme Nutrition Oncologie, 59000, Lille, France., Tard C; U1172, CHU de Lille, Centre de référence des maladies neuromusculaires Nord, Est, Ile-de-France, Service de neurologie, Lille, France.

Publikováno v: Journal of neurology [J Neurol] 2023 Apr; Vol. 270 (4), pp. 2237-2245. Date of Electronic Publication: 2023 Jan 24.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Could psychostimulant drug use among university students be related to ADHD symptoms? A preliminary study.

Autor: Caron C; Pharmacology Department, Psychiatry and Addiction Medicine Department, CHU Lille, Addictovigilance Center, Lille F-59000, France., Dondaine T; Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, Pharmacology Department, University of Lille, Inserm, CHU Lille, UMR-S1172, Lille F-59000, France., Bastien A; Psychiatry and Addiction Medicine Department, CHU Lille, Lille F-59000, France., Chérot N; University of Lille, CHU Lille, Institut Pasteur de Lille, EA 4483 - IMPECS - IMPact de l'Environnement Chimique sur la Santé humaine, Lille F-59000, France., Deheul S; Pharmacology Department, CHU Lille, Addictovigilance Center, France., Gautier S; Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, Pharmacology Department, University of Lille, Inserm, CHU Lille, UMR-S1172, Lille F-59000, France., Cottencin O; Department of Psychiatry and Addiction Medicine, Plasticity & SubjectivitY (PSY) team, Lille Neuroscience & Cognition Centre (LiNC), CHU Lille, INSERM U-1172, France., Moreau-Crépeaux S; University of Lille, University Student Health Services, France., Bordet R; Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, Pharmacology Department, University of Lille, Inserm, CHU Lille, UMR-S1172, Lille F-59000, France., Carton L; Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, Pharmacology Department, University of Lille, Inserm, CHU Lille, UMR-S1172, Lille F-59000, France. Electronic address: louise.carton@univ-lille.fr.

Publikováno v: Psychiatry research [Psychiatry Res] 2024 Jan; Vol. 331, pp. 115630. Date of Electronic Publication: 2023 Nov 25.

An overview of the use of psychoactive substances among students at the University of Lille during the COVID-19 health crisis: Results of the PETRA study.

Autor: Carton L; Pharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France., Bastien A; Department of Psychiatry and Addiction Medicine, CHU Lille, Lille, France., Chérot N; Department of Occupational Health, Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMP ECS - IMPact de l'Environnement Chimique sur la Santé humaine, Lille, France., Caron C; Pharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France.; Department of Psychiatry and Addiction Medicine, CHU Lille, Lille, France., Deheul S; Pharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France., Cottencin O; Department of Psychiatry and Addiction Medicine, Univ Lille, CHU Lille, INSERM U-1172, Plasticity & SubjectivitY (P SY) team, Lille Neuroscience & Cognition Centre (LiNC), Lille, France., Gautier S; Pharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France., Moreau-Crépeaux S; Univ. Lille, University Student Health Services, Lille, France., Dondaine T; Pharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France., Bordet R; Pharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France.

Publikováno v: Dialogues in clinical neuroscience [Dialogues Clin Neurosci] 2023 Dec; Vol. 25 (1), pp. 101-111. Date of Electronic Publication: 2023 Oct 14.